Brawn Biotech Fair Value
Brawn Biotech (BRAWN) average fair value is ₹13.69 across 4 valuation models — P/E Based Valuation, P/B Based Valuation, Asset-Based Valuation, Benjamin Graham Number, vs a current market price of ₹21.6 (-36.64%), fair value range ₹8.41–₹26.05. Examine BRAWN earnings for recent quarterly revenue, profit and EPS trends.
Fair Value Analysis Export
BRAWN Fair Value vs Current Price — Valuation Summary
BRAWN average fair value, fair value range, price gap and valuation status across 4 models: P/E Based Valuation, P/B Based Valuation, Asset-Based Valuation, Benjamin Graham Number. For live price and a broader fundamental view, visit BRAWN share price.
P/E Based Valuation
P/B Based Valuation
Asset-Based Valuation
Benjamin Graham Number
BRAWN Fair Value Analysis — Data Sources & Coverage
Brawn Biotech financial data sources, valuation methods applied and sector benchmarks used — 2023 financial year. See BRAWN price book multiple to compare market price against book value per share.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is 3 years old (2023).
BRAWN vs Healthcare Sector Peers — P/E, P/B & Market Cap
Brawn Biotech P/E ratio, P/B ratio and market capitalisation vs Healthcare sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| Jeena Sikho Lifecare | JSLL | 40.38 | 23.07 | ₹7,944 |
| Accretion Pharmaceuticals | ACCPL | 17.91 | 2.7 | ₹120 |
| Par Drugs & Chemical | PAR | 8.2 | 0.96 | ₹103 |
| Murae Organisor | MURAE | 2.86 | 0.2 | ₹41 |
| KRM Ayurveda | KRMAYURVED | - | 4.07 | ₹508 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.